Impact: Health and Welfare Impact, Economic, Commercial Impact
Description of impact
Adviser and consultant to PhaSER, a biotech company that will carry out mathematical modelling of drug-drug interactions (DDI) alongside 8HUM mouse validation.
Narrative
PhaSER, was formed in 2022 from 8HUM technology developed by Taconic and the University of Dundee over a 20 year period. PhaSER is collaborating with multiple companies, universities and charitable organisations to ensure that the 8HUM mouse model is used as widely as possible in drug discovery and development applications.
Impact status
Open
Category of impact
Health and Welfare Impact, Economic, Commercial Impact